215 related articles for article (PubMed ID: 34383675)
1. The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial.
Trojan A; Leuthold N; Thomssen C; Rody A; Winder T; Jakob A; Egger C; Held U; Jackisch C
J Med Internet Res; 2021 Aug; 23(8):e29271. PubMed ID: 34383675
[TBL] [Abstract][Full Text] [Related]
2. Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study.
Trojan A; Bättig B; Mannhart M; Seifert B; Brauchbar MN; Egbring M
JMIR Cancer; 2021 Mar; 7(1):e26950. PubMed ID: 33729162
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes.
Trojan A; Roth S; Atassi Z; Kiessling M; Zenhaeusern R; Kadvany Y; Schumacher J; Kullak-Ublick GA; Aapro M; Eniu A
JMIR Cancer; 2024 Apr; 10():e54178. PubMed ID: 38573759
[TBL] [Abstract][Full Text] [Related]
4. Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
Nyrop KA; Deal AM; Reeve BB; Basch E; Chen YT; Park JH; Shachar SS; Carey LA; Reeder-Hayes KE; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Lee JT; Wood WA; Muss HB
Cancer; 2020 Jul; 126(13):3084-3093. PubMed ID: 32315091
[TBL] [Abstract][Full Text] [Related]
5. Impact of Electronic Patient-Reported Outcomes on Unplanned Consultations and Hospitalizations in Patients With Cancer Undergoing Systemic Therapy: Results of a Patient-Reported Outcome Study Compared With Matched Retrospective Data.
Trojan A; Kühne C; Kiessling M; Schumacher J; Dröse S; Singer C; Jackisch C; Thomssen C; Kullak-Ublick GA
JMIR Form Res; 2024 May; 8():e55917. PubMed ID: 38710048
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial.
Wintner LM; Giesinger JM; Sztankay M; Bottomley A; Holzner B;
Trials; 2020 Oct; 21(1):849. PubMed ID: 33050917
[TBL] [Abstract][Full Text] [Related]
7. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
Richards HS; Blazeby JM; Portal A; Harding R; Reed T; Lander T; Chalmers KA; Carter R; Singhal R; Absolom K; Velikova G; Avery KNL
BMC Cancer; 2020 Jun; 20(1):543. PubMed ID: 32522163
[TBL] [Abstract][Full Text] [Related]
8. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
[TBL] [Abstract][Full Text] [Related]
9. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.
Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM
BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017
[TBL] [Abstract][Full Text] [Related]
10. Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study.
Iivanainen S; Alanko T; Vihinen P; Konkola T; Ekstrom J; Virtanen H; Koivunen J
JMIR Form Res; 2020 Oct; 4(10):e17898. PubMed ID: 33112242
[TBL] [Abstract][Full Text] [Related]
11. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.
Cirillo M; Venturini M; Ciccarelli L; Coati F; Bortolami O; Verlato G
Ann Oncol; 2009 Dec; 20(12):1929-35. PubMed ID: 19622510
[TBL] [Abstract][Full Text] [Related]
12. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
13. Patient perspectives in adverse event reporting after vaginal apical prolapse surgery.
Sung VW; Menefee S; Richter HE; Moalli PA; Andy U; Weidner A; Rahn DD; Paraiso MF; Jeney SE; Mazloomdoost D; Gilbert J; Whitworth R; Thomas S;
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38710268
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
15. Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.
Graf J; Sickenberger N; Brusniak K; Matthies LM; Deutsch TM; Simoes E; Plappert C; Keilmann L; Hartkopf A; Walter CB; Hahn M; Engler T; Wallwiener S; Schuetz F; Fasching PA; Schneeweiss A; Brucker SY; Wallwiener M
J Med Internet Res; 2022 Feb; 24(2):e16128. PubMed ID: 35133288
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.
Basch E; Wood WA; Schrag D; Sima CS; Shaw M; Rogak LJ; Kris MG; Shouery M; Bennett A; Atkinson T; Pietanza MC
Clin Trials; 2016 Jun; 13(3):331-7. PubMed ID: 26542025
[TBL] [Abstract][Full Text] [Related]
17. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
[TBL] [Abstract][Full Text] [Related]
18. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
[TBL] [Abstract][Full Text] [Related]
19. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
Basch E; Iasonos A; McDonough T; Barz A; Culkin A; Kris MG; Scher HI; Schrag D
Lancet Oncol; 2006 Nov; 7(11):903-9. PubMed ID: 17081915
[TBL] [Abstract][Full Text] [Related]
20. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
